Patents by Inventor Steven A. Curley

Steven A. Curley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11957619
    Abstract: The present disclosure concerns hyperthermic devices for treating vascular involvements related to cancer therapies, such as surgery. In specific embodiments, the device is configured to provide therapeutic heating to destroy vessel-encasing tumors while still protecting the vessel itself. In particular embodiments, the devices utilize two opposing semi-cylindrical shells that encase the vessel in need of treatment of a tumor thereon. In other devices, a flexible substrate is guided under and around the vessel and tumor thereon.
    Type: Grant
    Filed: May 12, 2017
    Date of Patent: April 16, 2024
    Assignee: Baylor College of Medicine
    Inventors: Stuart James Corr, Matthew James Ware, Steven A. Curley, Lam Nguyen
  • Patent number: 11959227
    Abstract: The creped multi-ply tissue products are durable, smooth and have low levels of Slough. In certain instances, the creped multi-ply tissue products are produced using a creping composition comprising a non-crosslinked latex polymer. The creped multi-ply tissue products may have a geometric mean tensile (GMT) from about 700 to about 1,500 g/3?, a basis weight from about 45 to about 60 gsm and a Slough less than about 2.00 mg, such as from about 0.10 to about 2.00 mg. The inventive tissue products also have good durability, such as a Durability Index from about 10.0 to about 20.0, smooth surfaces, such as a TS750 value from about 15.0 to 40.0 and low stiffness, such as a Stiffness Index less than about 10.0.
    Type: Grant
    Filed: March 31, 2023
    Date of Patent: April 16, 2024
    Inventors: Kevin Joseph Vogt, Mark William Sachs, Erin Ann McCormick, Devon Gaynelle Curley, Sara Jane Wille Stabelfeldt, Nathan John Vogel, Christopher Steven LeCount
  • Publication number: 20200038509
    Abstract: Embodiments of the disclosure concern methods and compositions for treating cancer in an individual that includes combination therapy comprising radiofrequency therapy and immunotherapy. In specific embodiments, utilization of the radiofrequency therapy invokes the immune system of the individual to provide an environment at the tumor that is receptive to native immune system components of the individual, and/or exogenously provided immune system components. In specific cases, the radiofrequency therapy enhances T cell localization to the tumor.
    Type: Application
    Filed: October 13, 2017
    Publication date: February 6, 2020
    Inventors: Stuart James Corr, Jared M. Newton, Steven A. Curley, Andrew G. Sikora
  • Publication number: 20190175397
    Abstract: The present disclosure concerns hyperthermic devices for treating vascular involvements related to cancer therapies, such as surgery. In specific embodiments, the device is configured to provide therapeutic heating to destroy vessel-encasing tumors while still protecting the vessel itself. In particular embodiments, the devices utilize two opposing semi-cylindrical shells that encase the vessel in need of treatment of a tumor thereon. In other devices, a flexible substrate is guided under and around the vessel and tumor thereon.
    Type: Application
    Filed: May 12, 2017
    Publication date: June 13, 2019
    Applicant: Baylor College of Medicine
    Inventors: Stuart James Corr, Matthew James Ware, Steven A. Curley, Lam Nguyen
  • Publication number: 20170209579
    Abstract: Embodiments of the disclosure concern methods and compositions for treating a subject with cancer, including overcoming resistance to a cancer drug using non-invasive radiotherapy frequency in combination with cancer drugs. In particular embodiments, radiofrequency therapy and cancer drugs in combination provide a synergistic benefit for cancer therapy. Use of radiofrequency therapy is an effective means to facilitate transport and perfusion of the cancer drugs in the subject.
    Type: Application
    Filed: July 24, 2015
    Publication date: July 27, 2017
    Inventors: Steven Curley, Stuart Corr, Rita Serda, Mustafa Raoof
  • Publication number: 20160263150
    Abstract: Various embodiments of the present disclosure pertain to methods of optimizing a treatment efficacy of a biological system by tuning a property of the biological system through the addition of an optimizing agent to the biological system. The tuning can include: (a) determining a property parameter of the biological system; (b) selecting an optimizing agent to be added to the biological system based on the determined property parameter; and (c) adding the optimizing agent to the biological system. The optimizing agent can include a kosmotropic material. The biological system can include a tissue, such as a tumor. The methods of the present disclosure can be utilized to enhance the efficacy of various treatments, such as the heat treatment of a biological system exposed to a radiofrequency field. The methods of the present disclosure can also include a step of treating the biological system.
    Type: Application
    Filed: March 10, 2016
    Publication date: September 15, 2016
    Applicants: Baylor College of Medicine, William Marsh Rice University
    Inventors: Nadia C. Lara, Andrew R. Barron, Stuart Corr, Steven Curley